# Mifepristone for Treatment of Uterine Fibroids

> **NCT00712595** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mediterranea Medica S. L.** · enrollment: 200 (actual)

## Conditions studied

- Uterine Fibroids

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** Mifepristone

## Key facts

- **NCT ID:** NCT00712595
- **Lead sponsor:** Mediterranea Medica S. L.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-01
- **Final completion:** 2009-03
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2009-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712595, "Mifepristone for Treatment of Uterine Fibroids". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00712595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*